151 related articles for article (PubMed ID: 31645680)
21. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
23. Association of KIR2DS4 and its variant KIR1D with leukemia.
Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
[No Abstract] [Full Text] [Related]
24. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
Iacobucci I; Storlazzi CT; Cilloni D; Lonetti A; Ottaviani E; Soverini S; Astolfi A; Chiaretti S; Vitale A; Messa F; Impera L; Baldazzi C; D'Addabbo P; Papayannidis C; Lonoce A; Colarossi S; Vignetti M; Piccaluga PP; Paolini S; Russo D; Pane F; Saglio G; Baccarani M; Foà R; Martinelli G
Blood; 2009 Sep; 114(10):2159-67. PubMed ID: 19589926
[TBL] [Abstract][Full Text] [Related]
25. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
26. Characterization of leukemias with ETV6-ABL1 fusion.
Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
[TBL] [Abstract][Full Text] [Related]
27. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
[TBL] [Abstract][Full Text] [Related]
28. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
[TBL] [Abstract][Full Text] [Related]
29. Management of ETV6-ABL1-positive childhood acute lymphoblastic leukaemia: report of two cases, a literature review and a call for action.
Zheng J; Wu S; Hu Y; Gao L; Ling J; Lu Q; Shi X; Xiao P; Ribeiro RC; Hu S
Br J Haematol; 2021 Apr; 193(1):197-200. PubMed ID: 33660258
[No Abstract] [Full Text] [Related]
30. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia.
Ma CC; Chai Y; Chen HL; Wang X; Gao Y; Hu WL; Xiang X
J Int Med Res; 2020 May; 48(5):300060520919237. PubMed ID: 32366154
[TBL] [Abstract][Full Text] [Related]
31. Recent trends in the treatment and prognosis of adult leukemia with characteristics of patients in Japan: transition during the fifteen years from 1971 to 1985.
Suzuki H; Ota K; Ohno R; Masaoka T; Shibata H; Kimura I; Amaki I; Miura Y; Uzuka Y; Kawato M
Jpn J Clin Oncol; 1989 Dec; 19(4):338-47. PubMed ID: 2607637
[TBL] [Abstract][Full Text] [Related]
32. Five most common prognostically important fusion oncogenes are detected in the majority of Pakistani pediatric acute lymphoblastic leukemia patients and are strongly associated with disease biology and treatment outcome.
Awan T; Iqbal Z; Aleem A; Sabir N; Absar M; Rasool M; Tahir AH; Basit S; Khalid AM; Sabar MF; Asad S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Haq R; Iqbal M; Akhtar T
Asian Pac J Cancer Prev; 2012; 13(11):5469-75. PubMed ID: 23317202
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
[TBL] [Abstract][Full Text] [Related]
34. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
[TBL] [Abstract][Full Text] [Related]
35. [Role of molecular screening for common fusion genes in the diagnosis and classification of leukemia].
Zhu YL; Zhang Y; Zhu P; Yang Y; Du JW; Liu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):236-9. PubMed ID: 15968309
[TBL] [Abstract][Full Text] [Related]
36. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.
Xu LP; Xu ZL; Zhang XH; Chen H; Chen YH; Han W; Chen Y; Wang FR; Wang JZ; Wang Y; Yan CH; Mo XD; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1080-1086. PubMed ID: 26995693
[TBL] [Abstract][Full Text] [Related]
38. High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia.
Lee JW; Kim Y; Cho B; Kim S; Jang PS; Lee J; Cho H; Lee GD; Chung NG; Kim M
Cancer Med; 2020 Jul; 9(13):4632-4639. PubMed ID: 32378810
[TBL] [Abstract][Full Text] [Related]
39. BCR-ABL rearrangement frequencies in chronic myeloid leukemia and acute lymphoblastic leukemia in Ecuador, South America.
Paz-y-Miño C; Burgos R; Morillo SA; Santos JC; Fiallo BF; Leone PE
Cancer Genet Cytogenet; 2002 Jan; 132(1):65-7. PubMed ID: 11801312
[TBL] [Abstract][Full Text] [Related]
40. Variant of ETV6/ABL1 gene is associated with leukemia phenotype.
Park J; Kim M; Lim J; Kim Y; Han K; Kim JS; Lee S; Kim HJ; Min WS
Acta Haematol; 2013; 129(2):78-82. PubMed ID: 23171811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
